Hao Yujun, Ren Wei
Department of Vascular Surgery, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Mar;26(3):336-40.
To analyze the influencing factors of no-reflow phenomenon after reperfusion in patients with chronic limb ischemia associated with acute thrombosis.
Between January 2009 and December 2010, 59 patients (67 limbs) with chronic limb ischemia associated with acute thrombosis were treated. According to whether the no-reflow phenomenon occurred or not, the patients were divided into no-reflow group (19 patients, 21 limbs) and reflow group (40 patients, 46 limbs). Logistic regression was used to analyze the roles of ischemia time, ischemia extent, smoking, hypertension, cardiovascular and cerebrovascular disease, diabetes, surgical procedure, platelet count, fibrinogen (FBG), prostaglandin 12 (PGI2), and thromboxane A2 (TXA2) on no-reflow phenomenon after reperfusion.
The results of the logistic regression analysis indicated that ischemia time (OR =7.196; 95%CI: 1.679-27.960), ischemia extent (OR = 5.116; 95% CI: 1.399-109.338), smoking (OR = 6.893; 95% CI: 3.704-2 291.003), diabetes (OR = 3.864; 95% CI: 1.009-421.702), PGI2 (OR = 7.985; 95% CI: 1.001-1.043), and TXA2 (OR = 7.643; 95% CI: 1.011-1.065) were the high risk factors of no-reflow phenomenon. The levels of TXA2 and FBG in no-reflow group were significantly increased and the level of PGI2 was decreased, showing significant differences when compared with the reflow group (P < 0.05). However, no significant difference was found in the platelet count between 2 groups (P > 0.05).
Ischemia extent and ischemia time are the main influencing factors of no-reflow phenomenon after reperfusion in patients with chronic limb ischemia associated with acute thrombosis, and the patients combined with smoking or diabetes are high risk population of the no-reflow phenomenon. Postoperative patients with no-reflow phenomenon are at a hypercoagulable state in vivo, in which prostacyclin plays an important role.
分析慢性肢体缺血合并急性血栓形成患者再灌注后无复流现象的影响因素。
选取2009年1月至2010年12月期间收治的59例(67条肢体)慢性肢体缺血合并急性血栓形成患者。根据是否发生无复流现象,将患者分为无复流组(19例,21条肢体)和复流组(40例,46条肢体)。采用Logistic回归分析缺血时间、缺血程度、吸烟、高血压、心脑血管疾病、糖尿病、手术方式、血小板计数、纤维蛋白原(FBG)、前列腺素12(PGI2)及血栓素A2(TXA2)对再灌注后无复流现象的作用。
Logistic回归分析结果显示,缺血时间(OR =7.196;95%CI:1.679 - 27.960)、缺血程度(OR = 5.116;95%CI:1.399 - 109.338)、吸烟(OR = 6.893;95%CI:3.704 - 2291.003)、糖尿病(OR = 3.864;95%CI:1.009 - 421.702)、PGI2(OR = 7.985;95%CI:1.001 - 1.043)及TXA2(OR = 7.643;95%CI:1.011 - 1.065)是无复流现象的高危因素。无复流组TXA2及FBG水平显著升高,PGI2水平降低,与复流组比较差异有统计学意义(P < 0.05)。两组血小板计数比较差异无统计学意义(P > 0.05)。
缺血程度和缺血时间是慢性肢体缺血合并急性血栓形成患者再灌注后无复流现象的主要影响因素,合并吸烟或糖尿病的患者是无复流现象的高危人群。术后发生无复流现象的患者体内处于高凝状态,前列环素在其中起重要作用。